General Information of the Compound
| Compound ID |
CP0211410
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide
Show/Hide
|
||||||||||||||||||
| Synonyms |
5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
5H-quino[8,7-c][1,2]benzothiazine 6,6-dioxide
5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide
AC1LD057
AKOS022139691
BDBM36894
CBDivE_011354
CHEBI:93609
CHEMBL1589921
CHEMBL428064
CYSOFAOLQAYKGU-UHFFFAOYSA-N
DNDI1318477
EU-0033328
HMS2479M21
MCULE-7323909600
MLS000038106
MolPort-002-134-452
NCGC00070544-03
Oprea1_666568
SCHEMBL11973195
SMR000040050
SR-01000388300
SR-01000388300-1
STL328289
ZINC230033
cid_659101
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H10N2O2S
|
||||||||||||||||||
| Molecular Weight |
282.324
|
||||||||||||||||||
| Canonical SMILES |
O=S1(=O)Nc2c(ccc3cccnc23)-c2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H10N2O2S/c18-20(19)13-6-2-1-5-11(13)12-8-7-10-4-3-9-16-14(10)15(12)17-20/h1-9,17H
Show/Hide
|
||||||||||||||||||
| InChIKey |
CYSOFAOLQAYKGU-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT05222, NF-kappa-B inhibitor alpha
Protein ID: PT06104, Solute carrier family 40 member 1
Clinical Information about the Compound
Drug 1 ( 5H-6-thia-4,5-diaza-chrysene 6,6-dioxide )
| Drug Name | 5H-6-thia-4,5-diaza-chrysene 6,6-dioxide | ||
|---|---|---|---|